Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 CAD | 0.00% | -1.49% | -15.38% |
25/04 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
25/04 | Microbix Collaborator Introduces New Lab Accreditation Program | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.38% | 33.05M | |
+24.68% | 46.71B | |
+48.83% | 41.8B | |
-1.14% | 41.52B | |
-5.86% | 29.55B | |
+10.88% | 25.78B | |
-20.31% | 19.26B | |
+2.29% | 12.14B | |
-4.05% | 12.08B | |
+29.02% | 11.98B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Microbix Brief: Q4 revenue was $4,264,229, relatively flat from Q4 2022 revenues